29.42
Precedente Chiudi:
$28.35
Aprire:
$28.44
Volume 24 ore:
501.31K
Relative Volume:
2.19
Capitalizzazione di mercato:
$1.30B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-1.97%
1M Prestazione:
+25.35%
6M Prestazione:
+284.07%
1 anno Prestazione:
+0.00%
Sionna Therapeutics Inc Stock (SION) Company Profile
Nome
Sionna Therapeutics Inc
Settore
Industria
Telefono
617-819-2020
Indirizzo
21 HICKORY DRIVE, SUITE 500, WALTHAM
Confronta SION con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
SION
Sionna Therapeutics Inc
|
29.42 | 1.25B | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-09-03 | Iniziato | RBC Capital Mkts | Sector Perform |
2025-09-03 | Iniziato | Raymond James | Strong Buy |
2025-03-04 | Iniziato | Guggenheim | Buy |
2025-03-04 | Iniziato | Stifel | Buy |
2025-03-04 | Iniziato | TD Cowen | Buy |
Sionna Therapeutics Inc Borsa (SION) Ultime notizie
What analysts say about Sionna Therapeutics Inc stockReal-Time Stock Alerts & Free Stock Trading Workshops - earlytimes.in
Sionna Therapeutics (NASDAQ:SION) Trading Up 6%What's Next? - MarketBeat
What indicators show strength in Sionna Therapeutics Inc.2025 Year in Review & Smart Money Movement Tracker - newser.com
Will Sionna Therapeutics Inc. bounce back from current support2025 Buyback Activity & Precise Buy Zone Tips - newser.com
What momentum indicators show for Sionna Therapeutics Inc. stockEntry Point & Long-Term Capital Growth Strategies - newser.com
Sionna Therapeutics (NASDAQ:SION) Receives "Sell (D)" Rating from Weiss Ratings - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Stock Price Down 3.5% After Insider Selling - MarketBeat
Insider Selling: Sionna Therapeutics (NASDAQ:SION) Director Sells 11,800 Shares of Stock - MarketBeat
Only Mass. biotech to go public this year grows headcount 71% - NBC Boston
Sionna Therapeutics Inc. stock trend outlook and recovery pathPortfolio Performance Report & Low Drawdown Momentum Trade Ideas - newser.com
Detecting price anomalies in Sionna Therapeutics Inc. with AIEntry Point & High Return Trade Guides - newser.com
Live market analysis of Sionna Therapeutics Inc.CPI Data & Free Community Supported Trade Ideas - newser.com
Using flow based indicators on Sionna Therapeutics Inc.Risk Management & Weekly High Return Stock Opportunities - newser.com
Multi factor analysis applied to Sionna Therapeutics Inc.July 2025 News Drivers & Expert-Curated Trade Recommendations - newser.com
Sionna Therapeutics (SION): Exploring Valuation After Recent 15% Share Price Climb - Sahm
Why hedge funds are buying Sionna Therapeutics Inc. stockPortfolio Value Summary & Low Risk High Reward Trade Ideas - newser.com
Statistical indicators supporting Sionna Therapeutics Inc.’s strengthWeekly Trade Analysis & Weekly High Conviction Ideas - newser.com
Will Sionna Therapeutics Inc. stock deliver strong dividend growth2025 Macro Impact & Daily Entry Point Trade Alerts - newser.com
Sionna Therapeutics (NASDAQ:SION) Shares Gap Down Following Insider Selling - Defense World
How currency fluctuations impact Sionna Therapeutics Inc. stockMarket Trend Review & Smart Allocation Stock Reports - newser.com
Sionna Therapeutics director sells shares worth $2.37 million By Investing.com - Investing.com South Africa
Sionna Therapeutics (NASDAQ:SION) Shares Down 5.1% After Insider Selling - Defense World
Sionna Therapeutics director sells shares worth $2.37 million - Investing.com
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference - GlobeNewswire
Sionna Therapeutics Inc Azioni (SION) Dati Finanziari
Non sono disponibili dati finanziari per Sionna Therapeutics Inc (SION). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):